BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23774388)

  • 1. An unusual presentation of malignant pleural mesothelioma.
    Lacle MM; van Oosterhout MF
    J Thorac Oncol; 2013 Jul; 8(7):e63-4. PubMed ID: 23774388
    [No Abstract]   [Full Text] [Related]  

  • 2. Immune checkpoint inhibitors in malignant pleural mesothelioma: promises and challenges.
    Ceresoli GL; Bonomi M; Sauta MG
    Expert Rev Anticancer Ther; 2016 Jul; 16(7):673-5. PubMed ID: 27224058
    [No Abstract]   [Full Text] [Related]  

  • 3. Is the patient with mesothelioma without hope?
    Maat AP; Cornelissen R; Bogers AJ; Takkenberg JJ
    Future Oncol; 2015; 11(24 Suppl):11-4. PubMed ID: 26638916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleural mesothelioma: tackling a deadly cancer.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2019 Feb; 7(2):99. PubMed ID: 30660508
    [No Abstract]   [Full Text] [Related]  

  • 5. Extrapleural pneumonectomy for malignant pleural mesothelioma: is this an operation that should now be consigned to history?
    Treasure T
    Future Oncol; 2015; 11(24 Suppl):7-10. PubMed ID: 26638915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Asbestos-induced malignant pulmonary and pleural diseases].
    Duell T
    MMW Fortschr Med; 2011 Jun; 153(22):38-41. PubMed ID: 21682033
    [No Abstract]   [Full Text] [Related]  

  • 7. A catalogue of treatment and technologies for malignant pleural mesothelioma.
    Schunselaar LM; Quispel-Janssen JM; Neefjes JJ; Baas P
    Expert Rev Anticancer Ther; 2016; 16(4):455-63. PubMed ID: 26943000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Year CheckMate743 outcomes: ringing in immunotherapy for the treatment of malignant pleural mesothelioma.
    Cedres S; Felip E
    Ann Oncol; 2022 May; 33(5):457-459. PubMed ID: 35306158
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Popat S; Baas P; Faivre-Finn C; Girard N; Nicholson AG; Nowak AK; Opitz I; Scherpereel A; Reck M;
    Ann Oncol; 2022 Feb; 33(2):129-142. PubMed ID: 34861373
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy Is a Good Standard Option for Patients With Malignant Pleural Mesothelioma, Despite the Real-World Results From Australia.
    Smesseim I; Baas P
    J Thorac Oncol; 2024 Apr; 19(4):547-550. PubMed ID: 38582547
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathologic complete remission of malignant pleural mesothelioma after combined modality treatment: a case report.
    Moubax K; Van Damme V; Nafteux P; Van den Heuvel M; Verbeken E; Lievens Y; Nackaerts K
    Acta Clin Belg; 2013; 68(5):386-8. PubMed ID: 24579249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Baas P; Fennell D; Kerr KM; Van Schil PE; Haas RL; Peters S;
    Ann Oncol; 2015 Sep; 26 Suppl 5():v31-9. PubMed ID: 26223247
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment.
    Bibby AC; Tsim S; Kanellakis N; Ball H; Talbot DC; Blyth KG; Maskell NA; Psallidas I
    Eur Respir Rev; 2016 Dec; 25(142):472-486. PubMed ID: 27903668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How I treat malignant pleural mesothelioma.
    Viscardi G; Di Liello R; Morgillo F
    ESMO Open; 2020 Mar; 4(Suppl 2):e000669. PubMed ID: 32156681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow the Leader? Can Malignant Pleural Mesothelioma Follow Non-small Cell Lung Cancer's Lead With Immunotherapy?
    Contreras N; Litle VR
    Ann Thorac Surg; 2022 Nov; 114(5):e361. PubMed ID: 35192794
    [No Abstract]   [Full Text] [Related]  

  • 16. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
    Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
    Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unusual presentation and location pleural malignant mesothelioma.
    Kumar A; Carcano C; Hadeh A; Lilenbaum R
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23761508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Novel Mini-Invasive Technique.
    Caronia FP; Fiorelli A; Santini M; Arrigo E
    Innovations (Phila); 2016; 11(6):444-447. PubMed ID: 27926627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative prediction of unresectability in malignant pleural mesothelioma.
    Burt BM; Lee HS; Raghuram AC; Strange C; Mason J; Strange T; Delgado J; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2512-2520.e1. PubMed ID: 32087959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.